Annex Rejected health claims
United Kingdom
| Application — Relevant provisions of Regulation (EC) No 1924/2006 | Nutrient, substance, food or food category | Claim | EFSA opinion reference |
|---|---|---|---|
| Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | Low-fat fermented milk with a combination of fructo-oligosaccharides (FOS) and live Lactobacillus rhamnosus GG (ATCC 53103), Streptococcus thermophilus (Z57) and Lactobacillus delbrueckii subsp. bulgaricus (LB2). | Consumption of low-fat fermented milk with a combination of fructo-oligosaccharides (FOS) and live Lactobacillus rhamnosus GG (ATCC 53103), Streptococcus thermophilus (Z57) and Lactobacillus delbrueckii subsp. bulgaricus (LB2) helps to reduce recurrence of lip cold sores caused by Herpes simplex virus infection in healthy susceptible individuals. | Q-2015-00488 |
| Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | FHI LFC24, a bovine milk-derived casein hydrolysate. | FHI LFC24 helps to regulate blood glucose levels following food consumption. | Q-2015-00755 |
| Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data | V0137, a DHA enriched fish oil. | V0137, in association with physical and intellectual training, helps to slow the age-related cognitive decline in domains such as memory and executive function. | Q-2016-00071 |